Nanobioanálisis
NBA


Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red de Cáncer (5)
2024
-
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance
Journal of Clinical Oncology, Vol. 42, Núm. 27, pp. 3247-3256
2023
-
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
Molecular Cancer, Vol. 22, Núm. 1
-
Chemo-Immunotherapy: A New Trend in Cancer Treatment
Cancers, Vol. 15, Núm. 11
2022
-
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)
Leukemia and Lymphoma, Vol. 63, Núm. 14, pp. 3438-3447
2019
-
Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma
Archives of Dermatological Research, Vol. 311, Núm. 5, pp. 369-376